Schroder Investment Management Group’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Buy
+18,113
New +$1.15M ﹤0.01% 1016
2025
Q4
Sell
-186,883
Closed -$10.1M 1161
2025
Q3
$10.1M Sell
186,883
-124,008
-40% -$5.11M 0.01% 661
2025
Q2
$10.3M Sell
310,891
-34,707
-10% -$1.21M 0.01% 632
2025
Q1
$14.9M Buy
345,598
+196,165
+131% +$9.02M 0.02% 572
2024
Q4
$7.05M Buy
149,433
+13,708
+10% +$712K 0.01% 712
2024
Q3
$7.17M Sell
135,725
-117,762
-46% -$6.56M 0.01% 728
2024
Q2
$13.7M Hold
253,487
0.02% 569
2024
Q1
$17.8M Buy
253,487
+142,340
+128% +$11M 0.02% 520
2023
Q4
$9.28M Buy
+111,147
New +$4.02M 0.01% 646

Other funds holding CYTK